Clorox (CLX) Non Operating Interest Expenses (2009 - 2026)

Clorox's Non Operating Interest Expenses history runs 18 years deep, the most recent figure standing at $177.0 million for Q1 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 14.49% year-over-year to $177.0 million in Q1 2026; TTM through Mar 2026 was $704.0 million, a 18.61% decrease from a year earlier, with the FY2025 full-year figure at $770.0 million, down 7.45% from the prior year.
• Non Operating Interest Expenses declined to $177.0 million in Q1 2026 per CLX's latest filing, from $190.0 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $266.0 million in Q2 2024 and bottomed at $153.0 million in Q1 2022.
• The 5-year median for Non Operating Interest Expenses is $190.0 million (2025), against an average of $189.9 million.
• Across the five-year window, Non Operating Interest Expenses surged 34.64% in 2023 and plunged 35.71% in 2025, its largest moves.
• Year by year, Non Operating Interest Expenses stood at $156.0 million in 2022, then increased by 19.23% to $186.0 million in 2023, then grew by 2.69% to $191.0 million in 2024, then slipped by 0.52% to $190.0 million in 2025, then declined by 6.84% to $177.0 million in 2026.
• Per Business Quant, the three latest CLX Non Operating Interest Expenses figures stand at $177.0 million (Q1 2026), $190.0 million (Q4 2025), and $166.0 million (Q3 2025).